TFRC and cancer: The use of iron chelating agents and the action of cytotoxic drugs such as TFR can inhibit the growth of cancer cells to a certain extent and improve their sensitivity to chemotherapy drugs by depriving iron or changing the metabolic ways of iron uptake and transfer in cancer cells (Moussa et al., 2019).